Geoff Meacham, Citi Research Managing Director, joins ‘Fast Money’ to talk competition in the weight loss drug space as Eli Lilly’s weight loss pill clears its latest trial.
Trending
- Australia’s consumer prices spike in July as electricity costs surge
- What’s likely to move the market in the next trading session
- Canada Goose draws take-private bids valuing it at $1.35 billion
- 'Fast Money' traders talk Pres. Trump tightening grip on the Federal Reserve and corporations
- China’s industrial profits slip 1.5% in July, slowest pace of decline in five months
- Microsoft removed protesters who stormed office Israel military work
- Off the Charts: Bull case for materials
- India tariffs, Nifty 50, Nikkei 225
Citi’s Geoff Meacham on Eli Lilly’s stock climbing as weight loss pill clears latest trial
